Szabo, A G, Thorsen, J, Iversen, K F, Levring, M B, Preiss, B, Helleberg, C, Breinholt, M F, Hermansen, E, Gjerdrum, L M R, Bønløkke, S T, Nielsen, K, Kjeldsen, E, Teodorescu, E M, Dokhi, M, Kurt, E, Strandholdt, C N, Andersen, M K & Vangsted, A J 2022, ' The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy ', American Journal of Hematology, vol. 97, no. 3, pp. E117-E120 . https://doi.org/10.1002/ajh.26449 Szabo, A G, Thorsen, J, Iversen, K F, Levring, M B, Preiss, B, Helleberg, C, Breinholt, M F, Hermansen, E, Gjerdrum, L M R, Bønløkke, S, Nielsen, K, Kjeldsen, E, Teodorescu, M, Dokhi, M, Kurt, E, Strandholdt, C N, Andersen, M K & Vangsted, A J 2021, ' The Clinical Course and Life Expectancy of Patients with Multiple Myeloma Who Discontinue Their First Daratumumab-Containing Line of Therapy ', Blood, vol. 138, no. Suppl. 1, 3779 . https://doi.org/10.1182/blood-2021-152070
Højholt, K L, Gregersen, H, Szabo, A G, Klausen, T W, Levring, M B, Preiss, B, Helleberg, C, Breinholt, M F, Hermansen, E, Rahbek Gjerdrum, L M, Bønløkke, S T, Nielsen, K, Kjeldsen, E, Iversen, K F, Teodorescu, E M, Kurt, E, Strandholdt, C, Andersen, M K & Vangsted, A J 2021, ' Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients ', Hematological Oncology, vol. 39, no. 4, pp. 521-528 . https://doi.org/10.1002/hon.2906